vs

Side-by-side financial comparison of Galecto, Inc. (GLTO) and Nuvve Holding Corp. (NVVE). Click either name above to swap in a different company.

Nuvve Holding Corp. is the larger business by last-quarter revenue ($1.9M vs $1.0M, roughly 1.9× Galecto, Inc.). Nuvve Holding Corp. runs the higher net margin — -314.5% vs -20053.5%, a 19739.1% gap on every dollar of revenue. On growth, Galecto, Inc. posted the faster year-over-year revenue change (339.0% vs 7.9%). Over the past eight quarters, Galecto, Inc.'s revenue compounded faster (50.5% CAGR vs 8.3%).

Galecto Biotech is a biotechnology company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer and inflammation. The company was founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark. The company today is incorporated in the U.S., and has its operating headquarters in Copenhagen, Denmark.

Nuvve Holding Corp. is a global technology provider specializing in vehicle-to-grid (V2G) solutions for electric vehicles. It delivers intelligent energy management platforms that allow EV batteries to feed excess stored power back to electrical grids, serving commercial fleet operators, utility firms, and residential EV owners across North America, Europe, and Asia-Pacific.

GLTO vs NVVE — Head-to-Head

Bigger by revenue
NVVE
NVVE
1.9× larger
NVVE
$1.9M
$1.0M
GLTO
Growing faster (revenue YoY)
GLTO
GLTO
+331.1% gap
GLTO
339.0%
7.9%
NVVE
Higher net margin
NVVE
NVVE
19739.1% more per $
NVVE
-314.5%
-20053.5%
GLTO
Faster 2-yr revenue CAGR
GLTO
GLTO
Annualised
GLTO
50.5%
8.3%
NVVE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GLTO
GLTO
NVVE
NVVE
Revenue
$1.0M
$1.9M
Net Profit
$-200.7M
$-6.1M
Gross Margin
Operating Margin
-20149.5%
-346.7%
Net Margin
-20053.5%
-314.5%
Revenue YoY
339.0%
7.9%
Net Profit YoY
-2877.8%
-19.0%
EPS (diluted)
$10.86
$-69.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GLTO
GLTO
NVVE
NVVE
Q4 25
$1.0M
$1.9M
Q3 25
$1.6M
Q1 25
$934.3K
Q4 24
$228.0K
$1.8M
Q3 24
$146.0K
$1.9M
Q2 24
$213.0K
$802.2K
Q1 24
$257.0K
$779.8K
Q4 23
$340.0K
$1.6M
Net Profit
GLTO
GLTO
NVVE
NVVE
Q4 25
$-200.7M
$-6.1M
Q3 25
$-4.5M
Q1 25
$-6.9M
Q4 24
$-6.7M
$-5.1M
Q3 24
$-3.9M
$-1.6M
Q2 24
$-5.3M
$-3.9M
Q1 24
$-5.5M
$-6.7M
Q4 23
$-6.5M
$-7.3M
Operating Margin
GLTO
GLTO
NVVE
NVVE
Q4 25
-20149.5%
-346.7%
Q3 25
-319.7%
Q1 25
-597.9%
Q4 24
-3114.9%
-314.2%
Q3 24
-2630.1%
-95.8%
Q2 24
-2618.3%
-718.5%
Q1 24
-2233.9%
-929.4%
Q4 23
-1962.1%
Net Margin
GLTO
GLTO
NVVE
NVVE
Q4 25
-20053.5%
-314.5%
Q3 25
-281.9%
Q1 25
-735.6%
Q4 24
-2956.6%
-285.2%
Q3 24
-2659.6%
-86.0%
Q2 24
-2506.1%
-491.0%
Q1 24
-2131.1%
-861.1%
Q4 23
-1904.4%
-442.9%
EPS (diluted)
GLTO
GLTO
NVVE
NVVE
Q4 25
$10.86
$-69.41
Q3 25
$-0.24
Q1 25
$-3.88
Q4 24
$-5.17
$-1050.64
Q3 24
$-3.39
$-2.47
Q2 24
$-4.92
$-6.70
Q1 24
$-5.05
$-16.89
Q4 23
$-27.66
$-368.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GLTO
GLTO
NVVE
NVVE
Cash + ST InvestmentsLiquidity on hand
$257.6M
$5.5M
Total DebtLower is stronger
$1.7M
Stockholders' EquityBook value
$240.4M
$-1.7M
Total Assets
$260.5M
$17.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GLTO
GLTO
NVVE
NVVE
Q4 25
$257.6M
$5.5M
Q3 25
$939.4K
Q1 25
$1.2M
Q4 24
$14.2M
$371.5K
Q3 24
$19.7M
$325.2K
Q2 24
$1.4M
Q1 24
$27.2M
$5.3M
Q4 23
$33.2M
$1.5M
Total Debt
GLTO
GLTO
NVVE
NVVE
Q4 25
$1.7M
Q3 25
$3.0M
Q1 25
$4.8M
Q4 24
$5.5M
Q3 24
$2.4M
Q2 24
Q1 24
Q4 23
$0
Stockholders' Equity
GLTO
GLTO
NVVE
NVVE
Q4 25
$240.4M
$-1.7M
Q3 25
$-1.4M
Q1 25
$-3.2M
Q4 24
$15.8M
$-1.3M
Q3 24
$20.9M
$3.0M
Q2 24
$23.6M
$3.3M
Q1 24
$28.2M
$6.6M
Q4 23
$32.3M
$7.5M
Total Assets
GLTO
GLTO
NVVE
NVVE
Q4 25
$260.5M
$17.4M
Q3 25
$16.8M
Q1 25
$16.5M
Q4 24
$17.1M
$16.8M
Q3 24
$23.4M
$18.3M
Q2 24
$18.5M
Q1 24
$32.5M
$23.5M
Q4 23
$38.2M
$21.0M
Debt / Equity
GLTO
GLTO
NVVE
NVVE
Q4 25
Q3 25
Q1 25
Q4 24
Q3 24
0.81×
Q2 24
Q1 24
Q4 23
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GLTO
GLTO
NVVE
NVVE
Operating Cash FlowLast quarter
$566.0K
$-4.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GLTO
GLTO
NVVE
NVVE
Q4 25
$566.0K
$-4.3M
Q3 25
$-5.1M
Q1 25
$-1.8M
Q4 24
$-4.9M
$-3.5M
Q3 24
$-3.7M
$-3.5M
Q2 24
$-4.1M
$-4.0M
Q1 24
$-5.9M
$-4.7M
Q4 23
$-11.5M
Free Cash Flow
GLTO
GLTO
NVVE
NVVE
Q4 25
Q3 25
$-5.1M
Q1 25
$-1.8M
Q4 24
$-3.5M
Q3 24
$-3.5M
Q2 24
$-4.0M
Q1 24
$-4.8M
Q4 23
FCF Margin
GLTO
GLTO
NVVE
NVVE
Q4 25
Q3 25
-317.6%
Q1 25
-194.9%
Q4 24
-196.0%
Q3 24
-182.9%
Q2 24
-501.7%
Q1 24
-611.2%
Q4 23
Capex Intensity
GLTO
GLTO
NVVE
NVVE
Q4 25
0.0%
Q3 25
0.2%
Q1 25
1.3%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
1.5%
Q1 24
5.2%
Q4 23
0.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GLTO
GLTO

Segment breakdown not available.

NVVE
NVVE

Engineering Services$1.1M57%
Other$838.4K43%

Related Comparisons